Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogsEliza Starczewska(UCLouvain), Françoise Bontemps(de Duve Institute)OncotargetMay 20, 201610.18632/oncotarget.9525Cited by 14SaveCiteExport RISWatch citationsRelated PapersReevaluation of ATR signaling in primary resting chronic lymphocytic leukemia cells: evidence for pro-survival or pro-apoptotic function|Oncotarget|2017|9